Loading...

POLYMED Poly Medicure Ltd Earnings Reports Announcement

Ply

PLYM

Poly Medicure Ltd

(POLYMED)

2026 Announcement

Investor Meeting Cancellation

Annual Secretarial Compliance

Audited Results (Standalone...

Dividend recommendation

Earnings Conference Call

Investor Presentation

Audited results

Investor Presentation

Dividend declaration

ESOP Grant under Scheme

One-on-one meetings

Earnings Conference

QIP Proceeds Utilization

Board meeting to approve re...

Subsidiary Acquisition

Regulatory Compliance

Trading Window Closure

Investor Conference

Call schedule update

Investor Meeting

One-on-one meeting

One-on-one meeting

One-on-one meetings

Investor Presentation

Investor Conference

Analyst meeting

One-on-one meetings

Monitoring Agency Report

Utilization deviation

Earnings Call Transcript

Earnings Call Recording

Newspaper Advertisement

Investor Presentation

Unaudited Results

Board meeting intimation

Regulatory Compliance

Volume Movement Clarification

insider trading compliance

Investor Meeting

One-on-one meetings with an...

One-on-one meetings

Investor meeting

Analysts Questions

QIP Utilization

QIP Monitoring MAR

Investor Meetings

Newspaper publication

Earnings Conference Call

Investor Presentation

Financial Results Declared

Board Meeting Outcome

Acquisition Completed

Earnings Call Announcement

Board Meeting Notice

Compliance Certificate

Acquisition Update

Investor Meet Outcome

Investor Presentation

Citieffe Acquisition

Investor Conference Call

Citieffe Acquisition

Citieffe Acquisition

Citieffe Acquisition

Acquisition Completed

Investor Meet Cancelled

Investor Call Scheduled

Investor Call Scheduled

Investor Meeting

Analyst Call Notice

PendraCare Acquisition

Investor Call Update

Annual General Meeting

Share Purchase Agreement

Investor Presentation

Company Acquisition

New Subsidiary Formed

New Subsidiary Created

Investor Call Update

Investor Call Scheduled

Acquisition Approved

Q1 FY26 Earnings

QIP Proceeds Update

Monitoring Agency Report

Investor Meetings

Financial Results Release

Earnings Call Update

New Executive Director

Stock Options Granted

Cost Auditor Re-Appointment

Director Changes

Q1 FY26 Results

Investor Presentation

Earnings Call Scheduled

Compliance Certificate

Postal Ballot Notice

Stock Options Grant

QIP Fund Utilization

Annual Compliance Report

Monitoring Agency Report

Earnings Call Transcript

Financial Results Published

Earnings Call Update

Financial Results Q4

Investor Presentation

Management Change

Director Resignation

Auditor Appointments

Earnings Call Announcement

Compliance Certificate

MDR Certification Achieved

QIP Funds Utilization

Monitoring Agency Report

Q3 FY25 Earnings

New Subsidiary Formed

Investor Meeting Outcome

Financial Results Q3

Investor Presentation

Earnings Call Notice

Compliance Certificate

Joint Venture Agreement

QIP Fund Utilization

Monitoring Report

Q2 FY25 Earnings

Earnings Call Audio

Management Change

Earnings Call Notice

Dematerialization Confirmation

Directorate Change

AGM Announcement

Equity Share Allotment

QIP Closure Announced

QIP Approval Update

Earnings Conference Call

Investor Presentation

Director Appointment

Certificate Submission

Regulatory Action

Newspaper Notice Publication

Fundraising Approval

Earnings Call Submission

Compliance Submission

Earnings Conference Call

Investors Presentation

Audit Declaration

Certificate Submission

Compliance Certificate

Certificate Submission

Allotment of ESOP

Earnings Conference Call

Earnings Conference Call

Certificate submission

Earnings Call Transcript

Related Party Transactions ...

Certificate under Regulatio...

AGM Advertisement

Financial Statements

Financial Results Discussion

Clarification of Volume Inc...

Financial Statements

Management Changes

Financial Statements

Change in Disclosure Requir...

External Links:

Data:

Q3 FY26 earnings call transcripts outline domestic growth, capex of INR 234 crore for new plants, US revenue potential amid tariff shifts, and guidance for Q4 revenue growth of 9–10% with ~20% H2 growth.

AI Assistant

Poly Medicure Ltd

2026

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.